By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian fluorescence and protein detection technologies firm Fluorotechnics last week reported revenues from customers for the first quarter of A$204,346 (US$224,006), down nearly nine-fold from A$1.8 million a year ago.

The company, which is in the middle of a turnaround effort, also reported net operating cash flows came in at a loss of A$273,609 for the three months ended March 31, compared to a loss of A$1.5 million a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.